News Merck backs startup bringing AI to fertility treatment It's no secret that fertility treatment is expensive and has a low success rate, placing a big financial and emotional burden on would-be parents.
News Gilead's twice-yearly PrEP drug is cleared by FDA Gilead has FDA approval for a twice-yearly PrEP drug, but could proposed cuts to US funding for HIV prevention programmes hinder its take-up?
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face